The Scientist

» antibiotics and cell & molecular biology

Most Recent

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: Fat's Immune Sentinels

Fat's Immune Sentinels

By | December 1, 2012

Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.

0 Comments

image: How Plants Feel

How Plants Feel

By | December 1, 2012

A hormone called jasmonate mediates plants' responses to touch and can boost defenses against pests.

1 Comment

image: Microchannel Masterpiece

Microchannel Masterpiece

By | December 1, 2012

A precision microfluidic system enables single-cell analysis of growth and division.

0 Comments

image: Chimp Patents Challenged

Chimp Patents Challenged

By | November 16, 2012

Three patents on transgenic apes in the European Union will be challenged by animal rights activists.

1 Comment

image: A Root Cause of Parkinson’s

A Root Cause of Parkinson’s

By | November 15, 2012

Misfolded α-synuclein proteins promote the spread of Parkinson’s pathology in mouse brains.

1 Comment

image: Inflammation for Regeneration

Inflammation for Regeneration

By | November 8, 2012

Inflammatory signals in injured zebrafish brains promote the growth of new neurons.

1 Comment

image: Gingers More Prone to Skin Cancer

Gingers More Prone to Skin Cancer

By | November 2, 2012

Researchers identify an unexpected molecular explanation for the higher incidence of skin cancer in redheads.

5 Comments

image: Coming to Terms

Coming to Terms

By | November 1, 2012

New noninvasive methods of selecting the most viable embryo could revolutionize in vitro fertilization.

11 Comments

image: Creative Emulsification

Creative Emulsification

By | November 1, 2012

Enhancing data collection from emulsion PCR reactions: three case studies

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech